Clinical experiences with molecular targeted therapy in lung cancer in China
about
The action and mechanism of myrislignan on A549 cells in vitro and in vivo.Association of Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphism With Lung Cancer Susceptibility.Development of epidermal growth factor receptor tyrosine kinase inhibitors against EGFR T790M. Mutation in non small-cell lung carcinoma.Establishment of lung cancer patient-derived xenograft models and primary cell lines for lung cancer study.
P2860
Clinical experiences with molecular targeted therapy in lung cancer in China
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Clinical experiences with molecular targeted therapy in lung cancer in China
@ast
Clinical experiences with molecular targeted therapy in lung cancer in China
@en
Clinical experiences with molecular targeted therapy in lung cancer in China
@nl
type
label
Clinical experiences with molecular targeted therapy in lung cancer in China
@ast
Clinical experiences with molecular targeted therapy in lung cancer in China
@en
Clinical experiences with molecular targeted therapy in lung cancer in China
@nl
prefLabel
Clinical experiences with molecular targeted therapy in lung cancer in China
@ast
Clinical experiences with molecular targeted therapy in lung cancer in China
@en
Clinical experiences with molecular targeted therapy in lung cancer in China
@nl
P2860
P356
P1433
P1476
Clinical experiences with molecular targeted therapy in lung cancer in China
@en
P2093
P2860
P304
P356
10.1111/1759-7714.12243
P407
P577
2015-07-01T00:00:00Z